MHRA Class 2 Medicines Recall: Levothyroxine 12.5mcg Tablets (Teva UK Limited)

Drug alert number: EL(23)A/06

Date issued: 2 March 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Levothyroxine 12.5mcg Tablets (Teva UK Limited) – PL 00289/1971

Batch Number Expiry Date Pack Size First Distributed
214052 10 2023 28 tablets 20 July 2022

Active Pharmaceutical Ingredients: Levothyroxine Sodium

Brief description of the problem

Teva UK Limited is recalling the above batch of Levothyroxine 12.5mcg Tablets in response to a lower than required assay result discovered during routine stability testing.

Advice for healthcare professionals

Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Full drug alert can be viewed here.

Further Information

For any Levothyroxine stock enquiries please contact the Teva UK Limited Customer Solutions team on 0800 590 502.

For more information or medical enquiries, please contact Teva UK Limited by phone on 020 7540 7117 or by email to medinfo@tevauk.com

Support the call for more funding by recording information about the informal advice you provide to patients over just one day.

Click Here